The Third Affiliated Hospital of Changchun University of Chinese Medicine
Changchun, China
Location status: Recruiting
NCT Number: NCT07176910
the study is to evaluated dopplar guided angiopuncture efficacy and safety in patients with dysmenorrhea
Interested in participating?
Request Info18 year–25 year
Female
Interventional
Not applicable
Changchun, China
Location status: Recruiting
to conduct angiopuncture, with dopplar located perforator points and also evaluate the spectrum before and after angiopuncture therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Primary dysmenorrhea diagnosis (≥6 months of menstrual pain scoring ≥2 on numerical rating scale) Regular menstrual cycles (28-32 days), menstrual period lasts 4 to 7 days No pelvic pathology on transvaginal ultrasound.
Exclusion criteria
coagulopathy (INR >1.5) recent analgesic use (48-hour washout) secondary dysmenorrhea confirmed by laparoscopy.
conducted angiopuncutre on patients of intervention group, and compare those patients pain scores before and after angiopuncture therapy.
Time frame: pre-treatment, immediate post-treatment, check up 1, check up 2, check up 3 (3 check ups lasts for 3 months post therapy, with each for 1 month)
to measure pain score before and after angiopuncture
Contact information is provided by the study sponsor or research team.
City University of Hong Kong
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06398990
Dysmenorrhea, Menstruation Disturbances
Istanbul, Ataşehir, Turkey (Türkiye)
View Trial DetailsNCT07679074
Behavior, Behavioral Symptoms
San Francisco, California, United States
View Trial DetailsNCT07628452
Dysmenorrhea, Menstruation Disturbances
Okāra, Punjab Province, Pakistan
View Trial DetailsNCT07576231
Dysmenorrhea, Menstruation Disturbances
Lahore, Punjab Province, Pakistan
View Trial Details